Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Well done Ken that was a fabulous ride for you from 780 levels or so to 1324p. Big ear to ear smile. Perfect timing. You can buy it cheaper now waiting for it to hit 1210p level perhaps.
CAML is doing much better than GLEN and will do so. Coal is the millstone around Glenda's neck.
Hitting lows in a long long time about 16 years. A doyen of a company. Used to admire their engines in various machinery. Has value in defense and 4 billion in reserve.
Still has a risk of going down if there is a significant 2nd wave and top heavy DOW as billy put it were to crash.
Ken must be saying woo....woo YES. Good for you. My limit order for FRES at 1190 never got filled over last 2 weeks. Happy it didn't from your point of view Ken as I have made the dosh and waiting patiently for any opportunistic low.
Sage your point of view is true but disappointing if invested and holding stocks long.
Eviking hemo does not have major pipelines and are looking for contract for investigations to do for elililly for autoimmune disease. May take the SP to 25p on that news.
Possibly worth a buy at 11p as it may drift there if there is no news this week.
TILS better punt as they have many pipelines and current drop gives an opportunity IMO.
This is the sad reality and Governments across the world kept giving false promises to people that effective vaccine will be here in September......if you rewind news including the King Clown Bo Jo
Unfortunately this hits the weakest in our community and those on zero hour contracts
https://www.cnn.com/2020/08/30/health/coronavirus-vaccine-two-doses/index.html
With FAAMG stocks being sought after by index traded funds, pension funds they are going into stratosphere. Add to that those who bet against Dow, Nasdaq, Tesla, Apple are getting margin calls driving stock up further. Cannot imagine the economic scenario to be that rosy going forward even with "Pent Up" demand with covid-19 lockdown to be driving stocks to all time high across the world.
S&P multiple was at 18 times when it was on cocaine at beginning of year and now it is eye watering 24 times. Yup no place money will earn you much with low interest rate by feds, which will continue for foreseeable future. Will not be surprised if the S&P multiple hits 28 before the rainbow bubble bursts.
Amazing is it not that only five stocks in US- FAAMG exceed Europe’s market cap.
Just APPLE is worth quarter of European stock market......mind boggling !!!!
A bit more complex details about dark pools....regulations by LSE etc.
For those interested.....experts here ignore the article as you know better :)
Article titled
Are security markets really rigged against retail investors?
https://www.investorschronicle.co.uk/shares/2018/11/09/the-truth-about-market-makers/
A bit more complex details about dark pools....regulations by LSE etc.
For those interested.....experts here ignore the article as you know better :)
Article titled
Are security markets really rigged against retail investors?
https://www.investorschronicle.co.uk/shares/2018/11/09/the-truth-about-market-makers/
for only those who need some idea, a decent weekend holiday read.
Market makers are the subject of much mystique. Are they human? Yes. Do they make money at your expense? Probably. Do they monitor Twitter and bulletin boards? Almost certainly. Wouldn’t you?
https://www.investorschronicle.co.uk/shares/2019/10/24/shake-your-market-maker/
for those who need some idea, a decent weekend holiday read
Market makers are the subject of much mystique. Are they human? Yes. Do they make money at your expense? Probably. Do they monitor Twitter and bulletin boards? Almost certainly. Wouldn’t you?
https://www.investorschronicle.co.uk/shares/2019/10/24/shake-your-market-maker/
If you read the full article you understand why I am making the comparison between Novacyt and Synairgen here. Most who invested in Nova will understand
Novacyt when they brought out the Covid-19 test in February with top of the range specificty and sensitivity had the aim to go it alone when they applied for FDA approval, French ANSM or UK MHRA.They looked at distributors only. They did not link up with big pharama or a big lab intially at that stage which did not have their own covid test. This led to a delayed FDA approval where the big labs of USA got approval within days of application compaed to a 2 months wait for Nova. Same happened around the world. Most govermnets were looking at fast throughtput through big labs and did not bother avout the covid tests having high Spec or Sen. French rejected it as a one gene test. Germany went with big labs like spain and italy. Rest of the world individual sales (even with Nova being on WHO list) did not get them the large sales volume they needed with only £73 million when we expected over £300 million US included. For testing tie up with consortium like AZN now ramped up testing in UK and use of Nova kits. They tied up with Bruker later. Even now many feel in USA there is a tie up with NDA, which might not be correct as all labs have their own test and FDA does not give a ****e about accuracy of tests. Anyway this is not allowing the SP to cross £3. Still a lot of us made huge gains in our investment there.
Synairgen being in a similar boat as Nova, a small company, cannot not go it alone with getting approvals with FDA, MHRA, EMA. They need a big partner or a pharma to take over fully and move SNG-001 (S Y N T E R F E R O N) forward. In USA AZN for example will be able to move it forward much more easily with FDA using their clout, presence and influence compared to a small company like Synarigen. Most of the regulators will be looking at issuing EUA and tying it in with larger phase 3 trials to go on at same time. A big pharma supporting phase 3 across continents with assured funding (if they buy SNG) with manufacture of SNG-001 in the large volume needed come October/ November has a much better chance of regulatros saying yes. Richard and Co will be looking at outright sale or big tie in and Astra Zeneca fits the requirement IMO and they are interest in COPD exacerbation treatment also.
Novacyt announced end August their Winterplex™ test panel whcih includes two gene targets specific to COVID-19, as well as gene targets for influenza A&B and respiratory syncytial virus (RSV).This will fit prefectly for the SNG-001 PHASE 3 trail for both Covid-19 and COPD treatments. Based on the result of Winterplex test in COPD patients they go into either trail making it easy to recruit patients. Good tie up of two good small UK gem companies in this scenario.
Those of us who saw Novacyt drop from 210p to 65p and rise thereafter and similarly Syanirgen drop from 70p to 32p and rise thereafter are p
as this has not happened for nearly 4 weeks at open MMs taking shares shares cheap to fill orders. Usual MM games. Price you pay for liqidity and have stop sell orders
Unverified treatment pushed through today by orangeman will be a good boost tomorrow for synairgen.
Sad to know from our own health treatment point of view in case we got covid was not announced. So far none out there for early phase of disease when covid ravages the lung. Hoping SNG-001 is releases ASAP.
we can have a good RNS ourselves about COPD study tomorrow at 7am or release of covid inhospital study article in Lancet. Lot to look forward to.
A craap unverified treatment pushed through today by orangeman will be a good boost tomorrow for synairgen..
Having said that people forget we can have a good RNS ourselves about COPD study tomorrow at 7am or release of covid inhospital study article in Lancet. Lot to look forward to.
It could be this if orangeman is backing US big pharma
REGN-COV2 is Regeneron's two-antibody '****tail' currently in late-stage clinical trials for the treatment and prevention of COVID-19 infection
The companies will collaborate on developing and manufacturing REGN-COV2; Regeneron will distribute REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.
https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-roche-collaborate-significantly-increase-global
Answer - our Children
8:25am update: UK retail sales surge past the peak before COVID
British retail sales surged past their pre-coronavirus level in July, the first full month that shops selling non-essential goods were open since the country went into lockdown in March.
Separate government borrowing data showed public debt rose above 2 trillion pounds ($2.65 trillion) in July for the first time and reached 100.5% of gross domestic product - its highest as a share of GDP since 1961.
The unexpectedly robust retail sales figures showed the strength of consumer demand even as other parts of the economy are struggling to recover from recent hefty losses.
Retail sales volumes rose by 3.6 percent from June - above all forecasts in a Reuters poll of economists - and were 1.4 percent higher than in July 2019, the Office for National Statistics said.
That represented a sharp recovery from double-digit falls in April and May.
Compared with February, before Britain was broadly affected by the pandemic, sales were 3.0 percent higher.
Alistair McQueen, head of savings and retirement at Aviva, said: “This uptick in retail consumption may help ease concerns over the fragility of the UK economy - but not for long.”
7.30am update: UK borrowing hits record level
Borrowing has now breached £150bn in the current financial year - a staggering £128.4bn more than between April and July last year.
It is the highest April-July total since records began in 1993.
The UK's public debt is now at £2 trillion - its highest point ever.
Long article but worth weekend read with a cup of coffee. incompetence + kickbacks at election
https://m.huffingtonpost.co.uk/entry/revealed-who-profited-from-the-uk-governments-coronavirus-spending-boom_n_5f3ef4e8c5b6305f32553f85?ri18n=true&ncid=APPLENEWS00001&guccounter=1&guce_referrer=aHR0cHM6Ly9hcHBsZS5uZXdzL0FPVWRRTkVfSlJ1T0hCZEhxREJfN3pR&guce_referrer_sig=AQAAAGVzA37P65xrNxTROtuR4RmVidhrDrjjraJHm4B21oHCfzz8rX4PFHGqGntiOLr8jTB6Y3EEZzrtY-sgU_2bl3131JO41OYvzh5uQKisU8gDq9mdc94cQIq5UoUpddxIoGWb9QpwUrvQXhd8PdEU0dgP3b1pqC7QtNQXiW8d5FjP
If above link does not work
shorturl.at/dgnSY
Nice to know you n family are busy with work and helping ur kids. Some pressures at work and emergency oncall rota in that period has delayed my confirmation for the meeting. Will contact Day soon. Thanks to the group for the invite.
OK verdict.... best name covering all aspects proposed by Jm
S Y N T E R F E R O N
https://www.ii.co.uk/news/london-market-pre-open-antofagasta-cuts-payout-as-covid-hits-copper-al1597906310977753000
News round up including federal reserve outlook
Billy if you mean stamp duty on CAML....then nope. Ken brought CAML to our attention in early March I think.
Ken you busy at work ? You used to post copper price with your early morning coffee.
Pete if you are trying to tell me Tiziana had dropped asking about Tils...well I have said the base for Tils is around 150 to 160p. No one can time a perfect entry point. Look at potential of share with pipeline and pick it after big tree shake if it looks attractive entry point. For me it was including trading with luck.